miRNA-122 Protects Mice and Human Hepatocytes from Acetaminophen Toxicity by Regulating Cytochrome P450 Family 1 Subfamily A Member 2 and Family 2 Subfamily E Member 1 Expression-Reference-Cited by-同舟云学术

miRNA-122 Protects Mice and Human Hepatocytes from Acetaminophen Toxicity by Regulating Cytochrome P450 Family 1 Subfamily A Member 2 and Family 2 Subfamily E Member 1 Expression

Published:2017-12 Issue:12 Volume:187 Page:2758-2774
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Chowdhary Vivek,Teng Kun-yu,Thakral Sharda,Zhang Bo,Lin Cho-hao,Wani Nissar,Bruschweiler-Li Lei,Zhang Xiaoli,James Laura,Yang Dakai,Junge Norman,Brüschweiler Rafael,Lee William M.,Ghoshal Kalpana

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference46 articles.

1. Drug-induced acute liver failure;Lee;Clin Liver Dis,2013

2. Oxidative stress during acetaminophen hepatotoxicity: sources, pathophysiological role and therapeutic potential;Du;Redox Biol,2016

3. Where are we now with paracetamol?;Dear;BMJ,2015

4. Mechanisms of acetaminophen-induced liver necrosis;Hinson;Handb Exp Pharmacol,2010

5. Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice;Chen;J Biol Chem,2008

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiplex Profiling of miR-122 for Preclinical and Clinical Evaluation of Drug-Induced Liver Injury by a Full-Scale Platform;ACS Nano;2024-08-28

2. Prenatal cigarette smoke exposure sensitizes acetaminophen-induced liver injury by modulating miR-34a-5p in male offspring mice;Frontiers in Cell and Developmental Biology;2024-07-30

3. Ultrasensitive upconverting nanoprobes for in situ imaging of drug-induced liver injury using miR-122 as the biomarker;Talanta;2024-07

4. Challenges and perspectives of liver tissue engineering: From cell therapy to bioprinting;International Journal of Bioprinting;2024-03-29

5. The challenges and potential of microRNA-based therapy for patients with liver failure syndromes and hepatocellular carcinoma;Expert Opinion on Therapeutic Targets;2024-03-03